Neuronal function of huntingtin associated protein Huntingtin-associated protein-1 (Hap1) was first identified as a cytoplasmic protein that interacts with the Huntington disease protein huntingtin. Like huntingtin, which is critical for embryonic development, Hap1 is also essential for animal survival, as deletion of the Hap1 gene in the mouse leads to a retarded growth and early postnatal death. However, unlike huntingtin, which is ubiquitously expressed, Hap1 is enriched in the brain and is expressed at different levels in various types of neurons, suggesting that Hap1 may function differently in different brain regions. Our recent studies also show that Hap1 forms a stable complex with Ahi1, a protein whose mutations cause Joubert syndrome, which is a brain developmental disorder. Growing evidence has demonstrated that Hap1 associates with microtubule-dependent transporters and that both huntingtin and Hap1 participate in intracellular trafficking. More importantly, mutant huntingtin can affect Hap1-mediated transport of vesicles and membrane receptors. While these findings have proved our previous hypothesis that Hap1 is involved in intracellular trafficking, the mechanism underlying the trafficking function of Hap1 remains to be investigated. Understanding this mechanism is important for unraveling the complex regulation of intracellular transport of membrane receptors and the neuropathology related to impaired intracellular trafficking. We hypothesize that Hap1 dysfunction may cause neuropathology in an age- and/or brain regional dependent manner and that phosphorylation of Hap1 regulates its function in endocytosis of membrane receptors.
In Aim 1, we will utilize the conditional Hap1 knockout mice to selectively deplete Hap1 expression in different brain regions and at different ages. We will then examine the neuropathology and behavioral phenotypes of Hap1 mutant mice to determine the critical function of Hap1.
In Aim 2, we will investigate how Hap1 participates in the endocytosis and recycling of neurotrophic receptors and whether mutant huntingtin affects Hap1-associated endocytosis of Trk receptors in an age-dependent manner. The studies aim to provide mechanistic insight into intracellular trafficking and endocytosis of membrane receptors and also offer a therapeutic target for the neuropathology caused by impaired endocytosis of neurotrophic receptors.
Characterization of the neuronal function of huntingtin associated protein (HAP1) will lead to increased understanding of the mechanisms for intracellular trafficking and pathogenesis of neuropathological conditions related to the impaired intracellular trafficking. ! !
|Yan, Sen; Tu, Zhuchi; Li, Shihua et al. (2018) Use of CRISPR/Cas9 to model brain diseases. Prog Neuropsychopharmacol Biol Psychiatry 81:488-492|
|Lim, Yoon; Wu, Linda Lin-Yan; Chen, Si et al. (2018) HAP1 Is Required for Endocytosis and Signalling of BDNF and Its Receptors in Neurons. Mol Neurobiol 55:1815-1830|
|Yang, Yang; Yang, Su; Guo, Jifeng et al. (2017) Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17. J Neurosci 37:9101-9115|
|Zhao, Ting; Hong, Yan; Yin, Peng et al. (2017) Differential HspBP1 expression accounts for the greater vulnerability of neurons than astrocytes to misfolded proteins. Proc Natl Acad Sci U S A 114:E7803-E7811|
|Tu, Zhuchi; Yang, Weili; Yan, Sen et al. (2017) Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos. Sci Rep 7:42081|
|Yang, Su; Yang, Huiming; Chang, Renbao et al. (2017) MANF regulates hypothalamic control of food intake and body weight. Nat Commun 8:579|
|Hong, Yan; Zhao, Ting; Li, Xiao-Jiang et al. (2017) Mutant Huntingtin Inhibits ?B-Crystallin Expression and Impairs Exosome Secretion from Astrocytes. J Neurosci 37:9550-9563|
|Li, Xiao-Jiang; Tu, Zhuchi; Yang, Weili et al. (2017) CRISPR: Established Editor of Human Embryos? Cell Stem Cell 21:295-296|
|Yang, Su; Chang, Renbao; Yang, Huiming et al. (2017) CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease. J Clin Invest 127:2719-2724|
|Cui, Yiting; Yang, Su; Li, Xiao-Jiang et al. (2017) Genetically modified rodent models of SCA17. J Neurosci Res 95:1540-1547|
Showing the most recent 10 out of 76 publications